Results 21 to 30 of about 2,098,413 (268)

Biomarkers for Chimeric Antigen Receptor T Cell Therapy in Acute Lymphoblastic Leukemia: Prospects for Personalized Management and Prognostic Prediction

open access: yesFrontiers in Immunology, 2021
Chimeric antigen receptor (CAR) T cell therapy represents a breakthrough in immunotherapy with the potential of ushering in a new era in cancer treatment.
Ruimin Hong   +11 more
doaj   +1 more source

Therapeutic Response and Antifungal Susceptibility to Fluconazole in Women with Vulvovaginal Candidiasis

open access: yesپیاورد سلامت, 2022
Background and Aim: Vulvovaginal candidiasis (VVC) is a vaginal fungal infection that mainly caused by Candida albicans. Among various treatments and their controversial outcomes, oral fluconazole has been accepted as a common and efficient treatment for
Zahra Vahedpoor   +4 more
doaj  

Spatial Alignment of Organoids Tracking Subclonal Chemotherapy Resistance in Pancreatic and Ampullary Cancer

open access: yesBioengineering, 2023
Pancreatic and ampullary cancers remain highly morbid diseases for which accurate clinical predictions are needed for precise therapeutic predictions.
Md Shahadat Hossan   +13 more
doaj   +1 more source

LncRNAs as regulators of chemoresistance and chemosensitivity in triple-negative breast cancer [PDF]

open access: yesGenetics and Molecular Biology
Triple-negative breast cancer (TNBC) is the most aggressive molecular subtype of breast cancer, characterized by significant heterogeneity and high recurrence rates.
Miguel Ángel Cáceres-Durán   +5 more
doaj   +2 more sources

Body composition parameters were associated with response to abiraterone acetate and prognosis in patients with metastatic castration‐resistant prostate cancer

open access: yesCancer Medicine, 2023
Objective To investigate the predictive value of body composition parameters for biochemical response to abiraterone acetate (AA) in metastatic castration‐resistant prostate cancer (mCRPC) patients with prior chemohormonal therapy.
Zhi‐Bin Ke   +10 more
doaj   +1 more source

Short-term prognosis, mid- and long-term clinical follow-up of bronchoscopic intervention therapy combined with bronchial artery embolization on massive hemoptysis

open access: yesFrontiers in Surgery
BackgroundTo explore the short-term prognosis, mid- and long-term clinical follow-up of bronchoscopic intervention therapy (BIT) combined with bronchial artery embolization (BAE) in the treatment of massive hemoptysis.MethodsPatients with massive ...
Kunying Li   +5 more
doaj   +1 more source

Characterization of cellular senescence patterns predicts the prognosis and therapeutic response of hepatocellular carcinoma

open access: yesFrontiers in Molecular Biosciences, 2022
Background: Hepatocellular carcinoma (HCC) is a prevalent malignancy with a high mortality rate. Cellular senescence, an irreversible state of cell cycle arrest, plays a paradoxical role in cancer progression.
Yuqin Tang   +3 more
doaj   +1 more source

Construction and validation of an angiogenesis-related scoring model to predict prognosis, tumor immune microenvironment and therapeutic response in hepatocellular carcinoma

open access: yesFrontiers in Immunology, 2022
BackgroundHepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world with high morbidity and mortality. Identifying an effective marker for predicting the prognosis and therapeutic response is extremely meaningful ...
Bo Tang   +5 more
doaj   +1 more source

Bridging the Loneliness Gap: Depression, Connectivity, and Isolation in Pediatric Oncology Patients and Their Peers

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Loneliness is associated with adverse physical and mental health outcomes and remains understudied in children and adolescents undergoing cancer therapy. Pediatric oncology patients may be at increased risk due to medical isolation and disruption of social networks.
Charlotte N. Stahlfeld   +5 more
wiley   +1 more source

Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives

open access: yesFrontiers in Immunology
Chimeric antigen receptor (CAR) T cell therapy holds enormous potential for the treatment of hematologic malignancies. Despite its benefits, it is still used as a second line of therapy, mainly because of its severe side effects and patient ...
Lucija Levstek   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy